Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Class A Common Stock, $0.0001 par value per share
-
Shares outstanding
-
23,944,922
-
Total 13F shares
-
2,299,817
-
Share change
-
+121,970
-
Total reported value
-
$4,755,556
-
Put/Call ratio
-
127%
-
Price per share
-
$2.07
-
Number of holders
-
38
-
Value change
-
+$256,107
-
Number of buys
-
15
-
Number of sells
-
11
Institutional Holders of Celularity Inc - Class A Common Stock, $0.0001 par value per share (CELU) as of Q3 2025
As of 30 Sep 2025,
Celularity Inc - Class A Common Stock, $0.0001 par value per share (CELU) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,299,817 shares.
The largest 10 holders included
C V STARR & CO INC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., Yorkville Advisors Global, LP, STATE STREET CORP, Valmark Advisers, Inc., CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, and HB Wealth Management, LLC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.